21 May 2013
Keywords: cell, genesys, gvax, trial, gets, idmc, go
Article | 21 January 2008
USA-based biotechnology firm Cell Genesys says that, following the successful completion of an independent data monitoring board review, it
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 January 2008
20 May 2013
© 2013 thepharmaletter.com